Back to 
Centiva Capital, LP
Centiva Capital, LP
MIRM
Showing 0 of 2 quarters
Position history for Centiva Capital, LP's holdings in Mirum Pharmaceuticals, Inc.
No. Centiva Capital exited its MIRM (Mirum Pharmaceuticals) position in Q3 2023. Its Q2 2023 13F listed 12,535 shares worth $324,280. Centiva Capital first reported MIRM in Q2 2023 and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.